Pregnancy and guillain-barré syndrome: A nationwide register cohort study

Neuroepidemiology

Volumn 15, Issue 4, 1996, Pages 192-200

  Jiang, G X ^a   De Pedro Cuesta, J ^a,c   Strigard K ^b,c   Olsson, T ^a   Link, H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

Author keywords

Epidemiology; Etiology; Guillain Barr eacute; syndrome; Postpartum; Pregnancy; Risk

Indexed keywords

ARTICLE; CHILDBIRTH; COHORT ANALYSIS; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; INFECTION RISK; PREGNANCY; REGISTER; REGRESSION ANALYSIS; SWEDEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; POLYRADICULONEUROPATHY; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS; REGRESSION ANALYSIS; RISK ASSESSMENT; SWEDEN;

EID: 0029928998     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000109907     Document Type: Article

References (29)

1. Asbury AK: Guillain-Barré syndrome: Historical aspects. Ann Neurol 1990;27(suppl):S2-S6.
2. MeFarlin DE: Immunological parameters in Guillain-Barré syndrome. Ann Neurol 1990;27(suppl): S25-S29.
3. Le Quesne PM: Neuropathy due to drugs; in Dyck PJ, Thomas PK, Lambert EH (eds): Peripheral Neuropathy. Philadelphia, Saunders, 1975, pp 1263-1280.
4. Sterman AB. Schaumburg HH: Neurotoxicity of selected drugs; in Spencer PS, Schaumburg HH (eds): Experimental and Clinical Neurotoxicology. Baltimore, Williams & Wilkins, 1980, pp 593-612.
5. Fagius F, Osterman PO, Sidén Â, Wiholm BE: Guillain-Barrc syndrome following zimeldine treatment. J Neurol Neurosurg Psychiatry 1985;48:65-69.
6. Boucquey D, Sindic CJM, Lamy M, Delmée M. Tomasi JP, Laterre EC: Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome. J Neurol Sci 1991; 104:56-63.
7. van den Berg LH, Marrink J, de Ja-ger AEJ, de Jong HJ, van Imhoff GW, Latov N, Sadiq SA: Anti-GM 1 antibodies in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1992;55:8-11.
8. Bctson J, Golden N: Guillain-Barrc syndrome in pregnancy. Obstet Gynecol 1960;15:391-393.
9. Ahlberg G, Ahlmark G: The Lan-dry-Guillain-Barré syndrome and pregnancy. Acta Obstet Gynecol Scand 1978;57:377-380.
10. Strigârd K: Experimental allergic neuritis; Studies on pathogenesis and immunoregulation. Acta Neurol Scand 1989;80(suppl):7-29.
11. Ansar AS, Young PR, Penhalc WJ: The effects of female sex steroids on the development of autoimmune thyroiditis in thymcctomizcd and irradiated rats. Clin Exp Immunol 1983;54:351-358.
12. Holmdahl R. Jansson L, Meycrson B, Klareskog L: Oestrogen induced suppression of collagen arthritis. I. Long term ocstradiol treatment of DBA/1 mice reduces severity and evidence of arthritis and decreases the anti-type II collagen immune response. Clin Exp Immunol 1987;70: 372-378.
13. Larsson P, Holmdahl R: Oestrogen induced suppression of collagen arthritis. II. Treatment of rats suppresses development of arthritis but docs not affect the anti-type II collagen humoral response. Scand J Immunol 1987;26:579-583.
14. Larsson P. Goldschmidt TJ, Klareskog L, Holmdahl R: Oestrogen-mediated suppression of collagen-induced arthritis in rats. Scand J Immunol 1989;30:741-747.
15. McAlpine D: Some aspects of the natural history; in McAlpine D (ed): Multiple Sclerosis: A Reappraisal. Edinburgh, Churchill Livingstone, 1972, pp 99-131.
16. Oostcrhuis HJGH (ed): Myasthenia Gravis. Clinical Neurology and Neurosurgery Monographs. Edinburgh. Churchill Livingstone, 1984, vol 5, pp. 27, 43-45.
17. Brenner T, Abramsky O: Suppression of clinical and experimental myasthenia gravis by alpha-fetoprotein. Neurology 1980;30:380-381.
18. Oka M, VainioU: Effect of pregnancy on the prognosis and serology of rheumatoid arthritis. Acta Rheumatol Scand 1966;12:47-52.
19. Abramsky O, Lubetzski-Korn I, Evron S, Brenner T: Suppressive effect of pregnancy on MS and EAE; in Alvord EC, Kies MW, Suckling AJ (eds): Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis. New York, Liss, 1984, pp 399-406.
20. Koobatian TJ, Birkhead GS, Schramm MM, Vogt RL: The use of hospital discharge data for public health surveillance of Guillain-Barre syndrome. Ann Neurol 1991; 30:618-621.
21. Thomas DG: Exact confidence limits for an odds ratio in a 2 x 2 table. Appl Stat 1971;20:105-110.
22. Jiang G-X, de Pedro-Cuesta J, Fredrikson S: Guillain-Barre syndrome in South-West Stockholm, 1973-1991, 1. Quality of registered hospital diagnoses and incidence. Acta Neurol Scand 1995:91:109-117.
23. Socialstyrelscn Statistik, Aborter 1985. Statistiska meddelanden se-rie: HS 33 SM 8702. Stockholm, SCB 1987, p 4.
24. McCombe PA, McManis PG, Frith JA, Pollard JD, McLeod JG: Chronic inflammatory demyelinat-ing polyradiculoneuropathy associated with pregnancy. Ann Neurol 1987:21:102-104.
25. Larsen JP, Kvile G, Nyland H: Epidemiology of the Guillain-Barre syndrome in the county of Horda-land, Western Norway. Acta Neurol Scand 1985;71:43-47.
26. Winner SJ, Evans JG: Age-specific incidence of Guillain-Barre syndrome in Oxfordshire. QJM 1990; 77:1297-1304.
27. Bak P: Guillain-Barre syndrome in a Danish county. Neurology 1985;35: 207-211.
28. Halls J, Bredkjasr C, Friis ML: Guillain-Barrc syndrome: Diagnostic criteria, epidemiology, clinical course and prognosis. Acta Neurol Scand 1988;78:118-122.
29. Keith AB: Effect of pregnancy on experimental allergic encephalomyelitis in guinea pigs and rats. J Neurol Sci 1978;38:317-326.